Previous studies show that GR is the crucial target of baicalin for antidepressant effects in olfactory bulb and hippocampus (Zhang et al., 2016; Gao et al., 2018), which indicates that GR is also the pivotal target of baicalin in hypothalamus for depression. This evidence concerns the gene NR3C1 and depressive symptom measurement.